- Morgan, TM, inventor; Lachesis Biosciences Ltd, assignee. Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders. WIPO PCT patent application WO 2016/049700. 2016 Apr 7.
- Morgan, TM, inventor; Lachesis Biosciences Ltd, assignee. Home diagnostic system. United States patent US 8,388,532
- Morgan TM. Deconvolution of Nasal Absorption of Rivastigmine in Humans and Future Clinical Development. J Prev Alz Dis 2016. 3(4):353; P2-39.
- Morgan TM. Absolute bioavailability and safety of a novel rivastigmine intranasal spray in healthy elderly individuals. J Prev Alz Dis 2015. 2(4):269-396; P2-55.